JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
102 hedge funds and large institutions have $92.7M invested in Jounce Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
–
Holders Change %
0%
% of All Funds
1.76%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
29
Reduced
35
Closed
13
Calls
$437K
Puts
$162K
Net Calls
+$275K
Net Calls Change
+$193K
